Bryoid compositions, methods of making and use thereof
AssigneeAphios Corporation
InventorTrevor Percival Castor
Life of this patent
Estimating the term…
Abstract
Embodiments of the present invention feature novel Bryoid compositions, methods of making and methods of treating disease
Claims10
A first Bryoid composition having a molecular weight of approximately 896-898 Amu (Mass+Sodium) and 873-875 Amu (monoisotopic mass) having a purity of approximately 50% to a crystal forming purity.
A second Bryoid composition having a molecular weight of approximately 910-912 Amu (Mass+Sodium) and 888-890 Amu (monoisotopic mass) having a purity of approximately 50% to a crystal forming purity.
A third Bryoid composition having a molecular weight of approximately 868-870 Amu (Mass+Sodium) and 846-848 Amu (monoisotopic mass)having a purity of approximately 50% to a crystal forming purity.
A fourth Bryoid composition having a molecular weight of approximately 895-897 Amu (Mass+Sodium) and 872-874 Amu (monoisotopic mass) having a purity of approximately 50% to a crystal forming purity.
A method of making a Bryoid composition comprising the steps isolating a Bryoid composition from a source of Bryoids and purifying the Bryoid composition to a purity of 50% and a crystal forming purity said Bryoid composition selected from the group of Bryoids consisting of the first Bryoid, second Bryoid, third Bryoid and fourth Bryoid.
A method of treating a disease responsive to Bryoid compositions comprising the step of administering an effective amount of a bryoid composition selected from the group of Bryoids consisting of the first Bryoid, second Bryoid, third Bryoid and fourth Bryoid.
Dependencies are inferred from the claim text.